Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Solid Tumour Section Short Communication t(11;22)(q24;q12) in giant cell tumour of bone Jean-Loup Huret Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France (JLH) Published in Atlas Database: June 2010 Online updated version : http://AtlasGeneticsOncology.org/Tumors/t1122q24q12GiantCellID6283.html DOI: 10.4267/2042/44989 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2011 Atlas of Genetics and Cytogenetics in Oncology and Haematology Protein From N-term to C-term: a transactivation domain (TAD) containing multiple degenerate hexapeptide repeats, 3 arginine/glycine rich domains (RGG regions), a RNA recognition motif, and a RanBP2 type Zinc finger. Role in transcriptional regulation for specific genes and in mRNA splicing. Clinics and pathology Disease Giant cell tumour of bone is a locally destructive tumor, usually seen in patients over 20 years of age, a borderline lesion between benign and malignant tumours, with a good prognosis, despite of recurrences and, more rarely, pulmonary metastases. The most frequent genetic finding is telomeric associations. Result of the chromosomal anomaly Genetics Hybrid Gene Note In a study by Scotlandi et al., 2000, was found that a minor population of cells from giant cell tumour of bone samples had an EWSR1/FLI1 transcript, but this was found in a high percentage of samples (13/15). Description 5' EWSR1 - 3' FLI1. EWSR1 exon 7 is fused in frame to FLI1 exon 6 and/or 5 (type 1 and type 2 fusions respectively), indicating, when both transcripts were produced in a given sample, genetic heterogeneity within the tumour. Genes involved and proteins Fusion Protein FLI1 Description Fusion of the N terminal transactivation domain of EWSR1 to the ETS type DNA binding domain of FLI1. Location 11q24 Protein From N-term to C-term: a 5' ETS domain, a Fli-1specific transcriptional activation domain, and a 3' ETS transcriptional activation domain. Member of ETS transcription factor gene family. FLI1 binds to DNA in a sequence-specific manner. References Scotlandi K, Chano T, Benini S, Serra M, Manara MC, Cerisano V, Picci P, Baldini N. Identification of EWS/FLI-1 transcripts in giant-cell tumor of bone. Int J Cancer. 2000 Aug 1;87(3):328-35 EWSR1 This article should be referenced as such: Location 22q12 Huret JL. t(11;22)(q24;q12) in giant cell tumour of bone. Atlas Genet Cytogenet Oncol Haematol. 2011; 15(3):299. Atlas Genet Cytogenet Oncol Haematol. 2011; 15(3) 299